Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Enter your registration information

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Chelsea Therapeutics CEOs Newsletter

Nirogy Therapeutics Appoints Simon Pedder, Ph.D., as Chief Executive Officer 12 Jan 2022 12:30 GMT
… Pedder, Ph.D., as Chief Executive Officer (CEO) and to the Company … the position from the founding CEO, Vincent Sandanayaka, Ph.D., … have Simon join us as CEO and on the Board. … and CEO of Cellectar Biosciences and of CEO of Chelsea Therapeutics before …
Stream Biomedical Appoints William D. Schwieterman, M.D. as Chief Executive Officer 28 Oct 2020 13:00 GMT
… within pharma--including roles as Chief Executive Officer and Chief Medical Officer … as Chief Medical Officer for Chelsea Therapeutics (2009-2014), a Charlotte North … of neurogenic orthostatic hypotension; as CEO for Mateon Therapeutics (2015-2019 …
Chelsea Therapeutics Advances Neurogenic Orthostatic Hypotension Registration Program 11 Feb 2010 02:16 GMT
… 10, 2010 (FinancialWire) — Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP) announced … Dr. Simon Pedder, president and CEO of Chelsea Therapeutics. “We are …
Chelsea Therapeutics Study Shows Symptomatic Benefits 25 Sep 2009 22:16 GMT
… 25, 2009 (FinancialWire) — Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP) announced … ’s president and CEO. “Further, we anticipate …
Chelsea Therapeutics Reaches Target Enrollment For Second Phase III Droxidopa Trial 11 Sep 2009 12:14 GMT
… 11, 2009 (FinancialWire) — Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP) has … ’s president and CEO. “Top-line data …

Continue to create your account.